Development of Novel ACK1/TNK2 Inhibitors Using a Fragment-Based Approach

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 17, 2015
Source ID
10.1021/jm501929n

Entities

People

  • Daniel Zhang
  • Harshani R. Lawrence
  • Harsukh Gevariya
  • Kiran Mahajan
  • Miles Huseyin
  • Nathan Tindall
  • Nicholas J. Lawrence
  • Nupam P. Mahajan
  • Sakib Kazi
  • Sevil Ozcan
  • Yunting Luo

Organizations

  • Congressionally Directed Medical Research Programs
  • National Cancer Institute
  • University of South Florida